APA (7th ed.) Citation

Schadendorf, D., Gutzmer, R., Eigentler, T., Lowy, I., Jankovic, V., Stankevich, E., . . . Guminski, A. Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: Primary analysis of fixed-dosing, long-term outcome of weight-based dosing. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Schadendorf, Dirk, et al. Phase 2 Study of Cemiplimab in Patients with Metastatic Cutaneous Squamous Cell Carcinoma: Primary Analysis of Fixed-dosing, Long-term Outcome of Weight-based Dosing. BMJ Publishing Group.

MLA (9th ed.) Citation

Schadendorf, Dirk, et al. Phase 2 Study of Cemiplimab in Patients with Metastatic Cutaneous Squamous Cell Carcinoma: Primary Analysis of Fixed-dosing, Long-term Outcome of Weight-based Dosing. BMJ Publishing Group.